Skip to main content
Erschienen in: Pediatric Nephrology 1/2005

01.01.2005 | Original Article

Abnormal left ventricular mass and aortic distensibility in pediatric dialysis patients

verfasst von: Renee F. Robinson, Milap C. Nahata, Elizabeth Sparks, Curt Daniels, Donald L. Batisky, John R. Hayes, John D. Mahan

Erschienen in: Pediatric Nephrology | Ausgabe 1/2005

Einloggen, um Zugang zu erhalten

Abstract

There is ample evidence that the same pathophysiological processes that affect cardiovascular function in adults with end-stage renal disease (ESRD) also operate in children with ESRD. In adults undergoing hemodialysis (HD), a good correlation has been established between left ventricular mass (LVM) and aortic distensibility (AD) as markers of cardiovascular disease progression; however, this correlation has not been established in children. Therefore, in this retrospective study we investigated some aspects of cardiovascular damage (i.e., LVM, LVMI, and AD) in children with ESRD undergoing HD ( n =9) or peritoneal dialysis (PD, n =9), and analyzed the relationship between AD, LVM, LVMI, pre-dialysis, post-dialysis blood pressure (BP), and demographic factors in children and adolescents with ESRD. Both LVM and AD were significantly greater in the dialysis population than in a control population derived from our institutional files ( P =0.015, P =0.001). LVM and LVMI in children undergoing HD (92.9±83.7 g, 80.1±31.1 g/cm) were not statistically different from the values in children on PD (130.0±89.2 g, 89.6±35.9 g/cm), ( P =0.3, P =0.5). AD in children on HD (2.2±0.55 cm2 * dynes–1*10–6) was significantly lower than in children on PD (2.7±0.54 cm2 * dynes–1*10–6), ( P =0.01). The findings in this study confirm earlier studies that demonstrated that LVMI is greater in children on dialysis. This study also demonstrates that abnormal vascular stiffness, as defined by AD, is present in these children. The degree of vascular stiffness in children receiving HD is greater than in children receiving PD. However, further study is needed to address how control of BP, uremia, and other factors may affect these abnormalities in children with ESRD.
Literatur
1.
Zurück zum Zitat Groothoff JW, Gruppen MP, Offringa M, Hutten J, Lilien MR, Van De Kar NJ, Wolff ED, Davin JC, Heymans HS (2002) Mortality and causes of death of end-stage renal disease in children: a Dutch cohort study. Kidney Int 61:621–629CrossRefPubMed Groothoff JW, Gruppen MP, Offringa M, Hutten J, Lilien MR, Van De Kar NJ, Wolff ED, Davin JC, Heymans HS (2002) Mortality and causes of death of end-stage renal disease in children: a Dutch cohort study. Kidney Int 61:621–629CrossRefPubMed
2.
Zurück zum Zitat Greaves SC, Sharpe DN (1992) Cardiovascular disease in patients with end-stage renal failure. Aust N Z J Med 22:153–159PubMed Greaves SC, Sharpe DN (1992) Cardiovascular disease in patients with end-stage renal failure. Aust N Z J Med 22:153–159PubMed
3.
Zurück zum Zitat (1992) Comorbid conditions and correlations with mortality risk among 3,399 incident hemodialysis patients. Am J Kidney Dis 20:32–38 (1992) Comorbid conditions and correlations with mortality risk among 3,399 incident hemodialysis patients. Am J Kidney Dis 20:32–38
4.
Zurück zum Zitat Wizemann V, Schafer R, Kramer W (1993) Follow-up of cardiac changes induced by anemia compensation in normotensive hemodialysis patients with left-ventricular hypertrophy. Nephron 64:202–206PubMed Wizemann V, Schafer R, Kramer W (1993) Follow-up of cardiac changes induced by anemia compensation in normotensive hemodialysis patients with left-ventricular hypertrophy. Nephron 64:202–206PubMed
5.
Zurück zum Zitat London GM, De Vernejoul MC, Fabiani F, Marchais SJ, Guerin AP, Metivier F, London AM, Llach F (1987) Secondary hyperparathyroidism and cardiac hypertrophy in hemodialysis patients. Kidney Int 32:900–907PubMed London GM, De Vernejoul MC, Fabiani F, Marchais SJ, Guerin AP, Metivier F, London AM, Llach F (1987) Secondary hyperparathyroidism and cardiac hypertrophy in hemodialysis patients. Kidney Int 32:900–907PubMed
6.
Zurück zum Zitat de Lima JJ, Abensur H, Krieger EM, Pileggi F (1996) Arterial blood pressure and left ventricular hypertrophy in haemodialysis patients. J Hypertens 14:1019–1024PubMed de Lima JJ, Abensur H, Krieger EM, Pileggi F (1996) Arterial blood pressure and left ventricular hypertrophy in haemodialysis patients. J Hypertens 14:1019–1024PubMed
7.
Zurück zum Zitat Conion PJ, Walshe JJ, Heinle SK, Minda S, Krucoff M, Schwab SJ (1996) Predialysis systolic blood pressure correlates strongly with mean 24-hour systolic blood pressure and left ventricular mass in stable hemodialysis patients. J Am Soc Nephrol 7:2658–2663PubMed Conion PJ, Walshe JJ, Heinle SK, Minda S, Krucoff M, Schwab SJ (1996) Predialysis systolic blood pressure correlates strongly with mean 24-hour systolic blood pressure and left ventricular mass in stable hemodialysis patients. J Am Soc Nephrol 7:2658–2663PubMed
8.
Zurück zum Zitat White WB (1992) Impact of the daily blood pressure load on the development of hypertensive heart disease. Cardiology 81:299–306PubMed White WB (1992) Impact of the daily blood pressure load on the development of hypertensive heart disease. Cardiology 81:299–306PubMed
9.
Zurück zum Zitat Groothoff JW, Gruppen MP, Offringa M, De Groot E, Stok W, Bos WJ, Davin JC, Lilien MR, Van De Kar NC, Wolff ED, Heymans HS (2002) Increased arterial stiffness in young adults with end-stage renal disease since childhood. J Am Soc Nephrol 13:2953–2961PubMed Groothoff JW, Gruppen MP, Offringa M, De Groot E, Stok W, Bos WJ, Davin JC, Lilien MR, Van De Kar NC, Wolff ED, Heymans HS (2002) Increased arterial stiffness in young adults with end-stage renal disease since childhood. J Am Soc Nephrol 13:2953–2961PubMed
10.
Zurück zum Zitat Cannella G, Paoletti E, Ravera G, Cassottana P, Araghi P, Mulas D, Peloso G, Delfino R, Messa P (2000) Inadequate diagnosis and therapy of arterial hypertension as causes of left ventricular hypertrophy in uremic dialysis patients. Kidney Int 58:260–268CrossRefPubMed Cannella G, Paoletti E, Ravera G, Cassottana P, Araghi P, Mulas D, Peloso G, Delfino R, Messa P (2000) Inadequate diagnosis and therapy of arterial hypertension as causes of left ventricular hypertrophy in uremic dialysis patients. Kidney Int 58:260–268CrossRefPubMed
11.
Zurück zum Zitat London GM (2002) Left ventricular alterations and end-stage renal disease. Nephrol Dial Transplant 17 [Suppl 1]:29–36 London GM (2002) Left ventricular alterations and end-stage renal disease. Nephrol Dial Transplant 17 [Suppl 1]:29–36
12.
Zurück zum Zitat London G (2001) Pathophysiology of cardiovascular damage in the early renal population. Nephrol Dial Transplant 16 [Suppl] 2:3–6 London G (2001) Pathophysiology of cardiovascular damage in the early renal population. Nephrol Dial Transplant 16 [Suppl] 2:3–6
13.
Zurück zum Zitat London GM, Pannier B, Guerin AP, Blacher J, Marchais SJ, Darne B, Metivier F, Adda H, Safar ME (2001) Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J Am Soc Nephrol 12:2759–2767PubMed London GM, Pannier B, Guerin AP, Blacher J, Marchais SJ, Darne B, Metivier F, Adda H, Safar ME (2001) Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J Am Soc Nephrol 12:2759–2767PubMed
14.
Zurück zum Zitat Parfrey PS, Harnett JD, Griffiths SM, Gault MH, Barre PE (1988) Congestive heart failure in dialysis patients. Arch Intern Med 148:1519–1525CrossRefPubMed Parfrey PS, Harnett JD, Griffiths SM, Gault MH, Barre PE (1988) Congestive heart failure in dialysis patients. Arch Intern Med 148:1519–1525CrossRefPubMed
15.
Zurück zum Zitat Belsha CW, Wells TG, McNiece KL, Seib PM, Plummer JK, Berry PL (1998) Influence of diurnal blood pressure variations on target organ abnormalities in adolescents with mild essential hypertension. Am J Hypertens 11:410–417CrossRefPubMed Belsha CW, Wells TG, McNiece KL, Seib PM, Plummer JK, Berry PL (1998) Influence of diurnal blood pressure variations on target organ abnormalities in adolescents with mild essential hypertension. Am J Hypertens 11:410–417CrossRefPubMed
16.
Zurück zum Zitat Daniels SR, Loggie JM, Khoury P, Kimball TR (1998) Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension. Circulation 97:1907–1911PubMed Daniels SR, Loggie JM, Khoury P, Kimball TR (1998) Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension. Circulation 97:1907–1911PubMed
17.
Zurück zum Zitat Daniels SR (1999) Hypertension-induced cardiac damage in children and adolescents. Blood Press Monit 4:165–170PubMed Daniels SR (1999) Hypertension-induced cardiac damage in children and adolescents. Blood Press Monit 4:165–170PubMed
18.
Zurück zum Zitat Daniels SR (2002) Cardiovascular sequelae of childhood hypertension. Am J Hypertens 15:61S–63SCrossRefPubMed Daniels SR (2002) Cardiovascular sequelae of childhood hypertension. Am J Hypertens 15:61S–63SCrossRefPubMed
19.
Zurück zum Zitat Chamontin B, Amar J, Barthe P, Salvador M (1994) Blood pressure measurements and left ventricular mass in young adults with arterial hypertension screened at high school check-up. J Hum Hypertens 8:357–361PubMed Chamontin B, Amar J, Barthe P, Salvador M (1994) Blood pressure measurements and left ventricular mass in young adults with arterial hypertension screened at high school check-up. J Hum Hypertens 8:357–361PubMed
20.
Zurück zum Zitat Sorof JM, Cardwell G, Franco K, Portman RJ (2002) Ambulatory blood pressure and left ventricular mass index in hypertensive children. Hypertension 39:903–908CrossRefPubMed Sorof JM, Cardwell G, Franco K, Portman RJ (2002) Ambulatory blood pressure and left ventricular mass index in hypertensive children. Hypertension 39:903–908CrossRefPubMed
21.
Zurück zum Zitat Sorof JM, Alexandrov AV, Cardwell G, Portman RJ (2003) Carotid artery intimal-medial thickness and left ventricular hypertrophy in children with elevated blood pressure. Pediatrics 111:61–66CrossRefPubMed Sorof JM, Alexandrov AV, Cardwell G, Portman RJ (2003) Carotid artery intimal-medial thickness and left ventricular hypertrophy in children with elevated blood pressure. Pediatrics 111:61–66CrossRefPubMed
22.
Zurück zum Zitat Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322:1561–1566PubMed Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322:1561–1566PubMed
23.
Zurück zum Zitat Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE (1996) Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 49:1379–1385PubMed Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE (1996) Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 49:1379–1385PubMed
24.
Zurück zum Zitat Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM (1999) Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99:2434–2439PubMed Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM (1999) Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99:2434–2439PubMed
25.
Zurück zum Zitat Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME, London GM (1998) Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension 32:570–574PubMed Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME, London GM (1998) Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension 32:570–574PubMed
26.
Zurück zum Zitat Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM (2001) Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 103:987–992PubMed Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM (2001) Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 103:987–992PubMed
27.
Zurück zum Zitat Pasierski TJ, Binkley PF, Pearson AC (1992) Evaluation of aortic distensibility with transesophageal echocardiography. Am Heart J 123:1288–1292CrossRefPubMed Pasierski TJ, Binkley PF, Pearson AC (1992) Evaluation of aortic distensibility with transesophageal echocardiography. Am Heart J 123:1288–1292CrossRefPubMed
28.
Zurück zum Zitat Wright JS, Cruickshank JK, Kontis S, Dore C, Gosling RG (1990) Aortic compliance measured by non-invasive Doppler ultrasound: description of a method and its reproducibility. Clin Sci 78:463–468PubMed Wright JS, Cruickshank JK, Kontis S, Dore C, Gosling RG (1990) Aortic compliance measured by non-invasive Doppler ultrasound: description of a method and its reproducibility. Clin Sci 78:463–468PubMed
29.
Zurück zum Zitat Matsumoto Y, Hamada M, Hiwada K (2000) Aortic distensibility is closely related to the progression of left ventricular hypertrophy in patients receiving hemodialysis. Angiology 51:933–941PubMed Matsumoto Y, Hamada M, Hiwada K (2000) Aortic distensibility is closely related to the progression of left ventricular hypertrophy in patients receiving hemodialysis. Angiology 51:933–941PubMed
30.
Zurück zum Zitat Troy BL, Pombo J, Rackley CE (1972) Measurement of left ventricular wall thickness and mass by echocardiography. Circulation 45:602–611PubMed Troy BL, Pombo J, Rackley CE (1972) Measurement of left ventricular wall thickness and mass by echocardiography. Circulation 45:602–611PubMed
31.
Zurück zum Zitat Sahn DJ, DeMaria A, Kisslo J, Weyman A (1978) Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58:1072–1083PubMed Sahn DJ, DeMaria A, Kisslo J, Weyman A (1978) Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58:1072–1083PubMed
32.
Zurück zum Zitat Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450–458CrossRefPubMed Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450–458CrossRefPubMed
33.
Zurück zum Zitat (1996) Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Pediatrics 98:649–658 (1996) Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Pediatrics 98:649–658
34.
Zurück zum Zitat Lorell BH, Carabello BA (2000) Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation 102:470–479PubMed Lorell BH, Carabello BA (2000) Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation 102:470–479PubMed
35.
Zurück zum Zitat Silberberg JS, Barre PE, Prichard SS, Sniderman AD (1989) Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 36:286–290PubMed Silberberg JS, Barre PE, Prichard SS, Sniderman AD (1989) Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 36:286–290PubMed
36.
Zurück zum Zitat Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE (1995) The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 5:2024–2031PubMed Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE (1995) The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 5:2024–2031PubMed
37.
Zurück zum Zitat Matsumoto Y, Honda T, Hamada M, Matsuoka H, Hiwada K (1996) Evaluation of aortic distensibility in patients with coronary artery disease by use of cine magnetic resonance. Angiology 47:149–155PubMed Matsumoto Y, Honda T, Hamada M, Matsuoka H, Hiwada K (1996) Evaluation of aortic distensibility in patients with coronary artery disease by use of cine magnetic resonance. Angiology 47:149–155PubMed
38.
Zurück zum Zitat Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A (2001) Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37:1236–1241PubMed Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A (2001) Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37:1236–1241PubMed
39.
Zurück zum Zitat Ghali JK, Liao Y, Simmons B, Castaner A, Cao G, Cooper RS (1992) The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease. Ann Intern Med 117:831–836PubMed Ghali JK, Liao Y, Simmons B, Castaner A, Cao G, Cooper RS (1992) The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease. Ann Intern Med 117:831–836PubMed
40.
Zurück zum Zitat Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE (1996) Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol 7:728–736PubMed Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE (1996) Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol 7:728–736PubMed
41.
Zurück zum Zitat Enia G, Mallamaci F, Benedetto FA, Panuccio V, Parlongo S, Cutrupi S, Giacone G, Cottini E, Tripepi G, Malatino LS, Zoccali C (2001) Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients. Nephrol Dial Transplant 16:1459–1464CrossRefPubMed Enia G, Mallamaci F, Benedetto FA, Panuccio V, Parlongo S, Cutrupi S, Giacone G, Cottini E, Tripepi G, Malatino LS, Zoccali C (2001) Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients. Nephrol Dial Transplant 16:1459–1464CrossRefPubMed
42.
Zurück zum Zitat Zeier M, Geberth S, Schmidt KG, Mandelbaum A, Ritz E (1993) Elevated blood pressure profile and left ventricular mass in children and young adults with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 3:1451–1457PubMed Zeier M, Geberth S, Schmidt KG, Mandelbaum A, Ritz E (1993) Elevated blood pressure profile and left ventricular mass in children and young adults with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 3:1451–1457PubMed
43.
Zurück zum Zitat Van Bortel LM, Struijker-Boudier HA, Safar ME (2001) Pulse pressure, arterial stiffness, and drug treatment of hypertension. Hypertension 38:914–921PubMed Van Bortel LM, Struijker-Boudier HA, Safar ME (2001) Pulse pressure, arterial stiffness, and drug treatment of hypertension. Hypertension 38:914–921PubMed
44.
Zurück zum Zitat Nishikimi T, Yoshihara F, Morimoto A, Ishikawa K, Ishimitsu T, Saito Y, Kangawa K, Matsuo H, Omae T, Matsuoka H (1996) Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension 28:22–30PubMed Nishikimi T, Yoshihara F, Morimoto A, Ishikawa K, Ishimitsu T, Saito Y, Kangawa K, Matsuo H, Omae T, Matsuoka H (1996) Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension 28:22–30PubMed
45.
Zurück zum Zitat Cowie MR, Struthers AD, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA, Sutton GC (1997) Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 350:1349–1353CrossRefPubMed Cowie MR, Struthers AD, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA, Sutton GC (1997) Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 350:1349–1353CrossRefPubMed
46.
Zurück zum Zitat Strozecki P, Adamowicz A, Nartowicz E, Odrowaz-Sypniewska G, Wlodarczyk Z, Manitius J (2001) Parathormon, calcium, phosphorus, and left ventricular structure and function in normotensive hemodialysis patients. Ren Fail 23:115–126CrossRefPubMed Strozecki P, Adamowicz A, Nartowicz E, Odrowaz-Sypniewska G, Wlodarczyk Z, Manitius J (2001) Parathormon, calcium, phosphorus, and left ventricular structure and function in normotensive hemodialysis patients. Ren Fail 23:115–126CrossRefPubMed
47.
Zurück zum Zitat Moon KH, Song IS, Yang WS, Shin YT, Kim SB, Song JK, Park JS (2000) Hypoalbuminemia as a risk factor for progressive left-ventricular hypertrophy in hemodialysis patients. Am J Nephrol 20:396–401CrossRefPubMed Moon KH, Song IS, Yang WS, Shin YT, Kim SB, Song JK, Park JS (2000) Hypoalbuminemia as a risk factor for progressive left-ventricular hypertrophy in hemodialysis patients. Am J Nephrol 20:396–401CrossRefPubMed
Metadaten
Titel
Abnormal left ventricular mass and aortic distensibility in pediatric dialysis patients
verfasst von
Renee F. Robinson
Milap C. Nahata
Elizabeth Sparks
Curt Daniels
Donald L. Batisky
John R. Hayes
John D. Mahan
Publikationsdatum
01.01.2005
Verlag
Springer-Verlag
Erschienen in
Pediatric Nephrology / Ausgabe 1/2005
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-004-1667-x

Weitere Artikel der Ausgabe 1/2005

Pediatric Nephrology 1/2005 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.